糖尿病注射笔市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00004552
  • Category : Life Sciences
  • No. of Pages : 150
立即购买

糖尿病注射笔市场预计在 2025 年至 2031 年期间的复合年增长率为 7.9%,市场规模将从 2024 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告按糖尿病注射笔市场类型(一次性注射笔、可重复使用注射笔)、疗法(糖尿病、生长激素疗法、生育、骨质疏松症、其他疗法)、最终用户(家庭护理、医院和诊所)和地域(北美、欧洲、亚太地区、中东和非洲以及南美和中美洲)进行细分。全球分析进一步细分为区域和主要国家。报告以美元为单位提供上述分析和细分的价值。

报告目的

The Insight Partners 撰写的《糖尿病注射笔市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

糖尿病注射笔市场细分

 

类型

  • 一次性注射笔
  • 可重复使用注射笔

治疗

  • 糖尿病
  • 生长激素治疗
  • 生育能力
  • 骨质疏松症
  • 其他疗法

最终用户

  • 家庭护理
  • 医院和诊所

地理

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

糖尿病注射笔市场:战略洞察

Diabetes Injection Pen Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

糖尿病注射笔市场增长动力

  • 糖尿病发病率不断上升:推动市场发展的主要因素之一是全球糖尿病病例的增长。2021 年,约有 5.37 亿 20 至 79 岁的成年人患有糖尿病,预计到 2030 年,这一数字可能会达到 6.43 亿。由于糖尿病发病率不断上升,必须频繁注射胰岛素,因此注射笔成为有效管理糖尿病的重要工具。
  • 老年人口发病率上升:随着人口老龄化,糖尿病和其他慢性病患者的数量也在增长。由于老年人更容易患糖尿病,这种人口结构变化增加了对注射笔等简单药物输送系统的需求。这一因素在近期推动了整体市场的增长,预计在预测期内将继续保持类似的趋势。
  • 偏好自行用药:自行用药越来越流行,尤其是在家庭护理环境中。与传统注射器和药瓶相比,患者更喜欢注射笔提供的便利性和易用性。从 2023 年到 2028 年,家庭护理市场预计将以 8.9% 的复合年增长率扩张。

糖尿病注射笔市场未来趋势

  • 技术发展:注射笔技术进步正在提高依从性和用户体验。智能功能等功能(可实现计时和剂量跟踪)越来越受欢迎。为了进一步推动市场扩张,企业正专注于创造以患者为中心的设计,以解决不适和可用性等问题。这一因素在近期推动了整体市场的增长,预计在预测期内将继续保持类似的趋势。
  • 优惠政策:得益于政府的优惠政策,该行业正在不断扩大,这些政策支持价格合理的注射剂并提高医疗保健的可及性。由于保险覆盖范围和报销选择范围扩大,患者可以更轻松地获得这些设备。这些因素在近期推动了整体市场的增长,预计在预测期内将继续保持类似的趋势。
  • 成本效益:从长远来看,可重复使用的智能胰岛素笔比一次性胰岛素笔更具成本效益。患者只需更换胰岛素笔芯而不是整支笔,就可以节省大量长期糖尿病护理费用。这一特点在医疗费用成为问题的地方尤其具有吸引力。

糖尿病注射笔市场机会

  • 实时数据采集:使用蓝牙技术,智能胰岛素笔可以即时记录和发送胰岛素剂量信息。通过自动记录每次剂量(包括给药时间和剂量),此功能可减少剂量记录中的错误,并且无需人工跟踪。
  • 与连续血糖监测仪 (CGM) 集成:连续血糖监测仪和其他血糖监测设备可以连接到智能胰岛素笔。通过这种集成,可以全面了解患者的血糖水平和胰岛素剂量历史。患者可以利用这些综合数据来指导胰岛素给药决策,从而改善血糖控制。
  • 数据共享功能:智能胰岛素笔的连接功能使与医疗专业人员共享剂量信息变得简单。此功能使基于实时数据分析的更明智的医疗咨询和治疗计划修改成为可能。医务人员能够远程监控患者的胰岛素使用情况并提供及时建议。

 

糖尿病注射笔市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响糖尿病注射笔市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的糖尿病注射笔市场细分和地理位置。

Diabetes Injection Pen Market
  • 获取糖尿病注射笔市场的区域特定数据

糖尿病注射笔市场报告范围

报告属性细节
2024 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2025 - 2031)7.9%
史料2021-2023
预测期2025-2031
涵盖的领域按类型
  • 一次性注射笔
  • 可重复使用注射笔
通过治疗
  • 糖尿病
  • 生长激素治疗
  • 生育能力
  • 骨质疏松症
  • 其他疗法
按最终用户
  • 家庭护理
  • 医院和诊所
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 诺和诺德
  • 礼来公司
  • 赛诺菲
  • 默克公司
  • 伊普索梅德公司
  • F.霍夫曼-罗氏有限公司
  • 屋宇署
  • 辉瑞公司
  • 哈泽尔迈尔

 

糖尿病注射笔市场参与者密度:了解其对业务动态的影响

糖尿病注射笔市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在糖尿病注射笔市场运营的主要公司有:

  1. 诺和诺德
  2. 礼来公司
  3. 赛诺菲
  4. 默克公司
  5. 伊普索梅德公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Diabetes Injection Pen Market

 

  • 了解糖尿病注射笔市场顶级关键参与者概况

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖了糖尿病注射笔市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,糖尿病注射笔市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
diabetes-injection-pen-market-report-deliverables-img1
diabetes-injection-pen-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


What is the expected CAGR of the Diabetes Injection Pen Market?

The Diabetes Injection Pen Market is estimated to witness a CAGR of 7.9% from 2023 to 2031

Which end user segment held the largest share in 2023?

Hospitals segment held the largest share in 2023.

Which country held the second largest share in Europe in 2023?

In Europe, the UK held the second largest share in 2023.

Which region held the largest share in 2023?

North America held the largest share in 2023 and is expected to retain its dominance during the forecast period

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Novo Nordisk
2. Eli lilly and company
3. Sanofi
4. Merck & Co., Inc.
5. Ypsomed AG
6. F. Hoffman-La Roche Ltd.
7. BD
8. Pfizer Inc.
9. Haselmeier
10. Owen Mumford
diabetes-injection-pen-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.